A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, with significantly grea
Since anti-PD1 is the leading immunotherapy treatment in cancer patients, such an achievement can impact the quality of life of thousands of cancer patients worldwide every day.
Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity embopress.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from embopress.org Daily Mail and Mail on Sunday newspapers.
Israel Scores Success against Skin Cancer eturbonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eturbonews.com Daily Mail and Mail on Sunday newspapers.